144 related articles for article (PubMed ID: 25683711)
1. Disruption of the PHRF1 Tumor Suppressor Network by PML-RARα Drives Acute Promyelocytic Leukemia Pathogenesis.
Prunier C; Zhang MZ; Kumar S; Levy L; Ferrigno O; Tzivion G; Atfi A
Cell Rep; 2015 Feb; 10(6):883-890. PubMed ID: 25683711
[TBL] [Abstract][Full Text] [Related]
2. Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivation.
Ettahar A; Ferrigno O; Zhang MZ; Ohnishi M; Ferrand N; Prunier C; Levy L; Bourgeade MF; Bieche I; Romero DG; Colland F; Atfi A
Cell Rep; 2013 Aug; 4(3):530-41. PubMed ID: 23911286
[TBL] [Abstract][Full Text] [Related]
3. Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling.
Faresse N; Colland F; Ferrand N; Prunier C; Bourgeade MF; Atfi A
EMBO J; 2008 Jul; 27(13):1804-15. PubMed ID: 18511908
[TBL] [Abstract][Full Text] [Related]
4. Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling.
Seo SR; Ferrand N; Faresse N; Prunier C; Abécassis L; Pessah M; Bourgeade MF; Atfi A
Mol Cell; 2006 Aug; 23(4):547-59. PubMed ID: 16916642
[TBL] [Abstract][Full Text] [Related]
5. PHRF1 promotes the class switch recombination of IgA in CH12F3-2A cells.
Lee JY; Chou NL; Yu YR; Shih HA; Lin HW; Lee CK; Chang MS
PLoS One; 2023; 18(8):e0285159. PubMed ID: 37540725
[TBL] [Abstract][Full Text] [Related]
6. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
[TBL] [Abstract][Full Text] [Related]
7. PCTA: a new player in TGF-beta signaling.
Liu F
Sci Signal; 2008 Nov; 1(46):pe49. PubMed ID: 19018012
[TBL] [Abstract][Full Text] [Related]
8. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL.
di Masi A; Cilli D; Berardinelli F; Talarico A; Pallavicini I; Pennisi R; Leone S; Antoccia A; Noguera NI; Lo-Coco F; Ascenzi P; Minucci S; Nervi C
Cell Death Dis; 2016 Jul; 7(7):e2308. PubMed ID: 27468685
[TBL] [Abstract][Full Text] [Related]
9. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.
Nervi C; Ferrara FF; Fanelli M; Rippo MR; Tomassini B; Ferrucci PF; Ruthardt M; Gelmetti V; Gambacorti-Passerini C; Diverio D; Grignani F; Pelicci PG; Testi R
Blood; 1998 Oct; 92(7):2244-51. PubMed ID: 9746761
[TBL] [Abstract][Full Text] [Related]
10. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
12. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
13. PHRF1 promotes migration and invasion by modulating ZEB1 expression.
Lee JY; Fan CC; Chou NL; Lin HW; Chang MS
PLoS One; 2020; 15(7):e0236876. PubMed ID: 32730336
[TBL] [Abstract][Full Text] [Related]
14. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
15. PML-RARα interferes with erythropoiesis by repressing LMO2 in acute promyelocytic leukaemia.
Yang X; Tan Y; Wang P; Zhang H; Zhao M; Zhao X; Wang K
J Cell Mol Med; 2018 Dec; 22(12):6275-6284. PubMed ID: 30320491
[TBL] [Abstract][Full Text] [Related]
16. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
[TBL] [Abstract][Full Text] [Related]
17. PML-RARα stabilized by zinc in human acute promyelocytic leukemia NB4 cells.
Zhu B; Wang JY; Zhou JJ; Zhou F; Cheng W; Liu YT; Wang J; Chen X; Chen DH; Luo L; Hua ZC
J Inorg Biochem; 2017 Oct; 175():92-100. PubMed ID: 28743050
[TBL] [Abstract][Full Text] [Related]
18. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
Jing Y
Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of promyelocytic leukemia/retinoic acid receptor-alpha (PML/RARalpha) expression and leukemogenic activity by DNA/LNA chimeric antisense oligos.
Caprodossi S; Galluzzi L; Biagetti S; Della Chiara G; Pelicci PG; Magnani M; Fanelli M
Oncol Res; 2005; 16(3):157-66. PubMed ID: 16925116
[TBL] [Abstract][Full Text] [Related]
20. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
